CNTB NASDAQ
Connect Biopharma Holdings Limited
1W: -14.2%
1M: -66.4%
3M: -60.7%
YTD: -63.2%
1Y: -38.2%
3Y: +27.0%
5Y: -95.7%
$0.93
-0.05 (-5.38%)
Weekly Expected Move ±21.6%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2026-03-30
Earliest Filing
2026-03-30
Latest Filing
partner: 1
Counterparties (Filed by CNTB)
1 relationshipsCompanies named in CNTB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Simcere Pharmaceutical Co., Ltd. | — | partner | Partner conducting Phase 3 clinical study for the Company | 2026-03-30 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-30 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-04-23 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-31 | Earnings Release; Exhibits | View | |
| 2026-03-30 | Material Agreement; Unregistered Equity Sales; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2025-12-23 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-16 | Regulation FD Disclosure | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-22 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-07-21 | Termination of Material Definitive Agreement; Financial Statements and Exhibits | View | |
| 2025-07-17 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-14 | Regulation FD Disclosure; Other Events | View | |
| 2025-05-13 | Regulation FD Disclosure; Other Events | View | |
| 2025-04-01 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-03-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR